Overactive Bladder
Efficacy of Combined Therapy With Silodosin and Solifenacin in Females With Overactive Bladder.
January 26, 2025
Onabotulinum Toxin A-Led Urinary Tract Infections-Should we Safeguard? A Randomized Controlled Trial.
January 26, 2025
Predicting Elevated Postvoid Residual Urine Volume Following OnabotulinumtoxinA Treatment for Overactive Bladder: A Pilot Study.
January 17, 2025
Association between cardiometabolic index and overactive bladder in adult American women: A cross-sectional study.
January 17, 2025
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder.
January 17, 2025
Systematic review and meta-analysis on the association of metabolic syndrome in women with overactive bladder.
January 10, 2025
Trends in Medicare Coverage of Overactive Bladder Medications in the United States.
January 10, 2025
Complicated Overactive Bladder Management.
January 10, 2025
The Association Between Anthropometric Indices and Overactive Bladder (OAB): A Cross-Sectional Study From the NHANES 2005-2018.
January 3, 2025
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence.
January 3, 2025
Clinical Features and Current Pharmacotherapy of OAB in Practice: Ideal and Reality.
December 29, 2024
Endocrine disruptors and bladder function: the role of phthalates in overactive bladder.
December 29, 2024